Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Swiss Government aims...

    Swiss Government aims to legalise medical marijuana to treat cancer patients

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-06-27T09:00:38+05:30  |  Updated On 27 Jun 2019 9:00 AM IST
    Swiss Government aims to legalise medical marijuana to treat cancer patients

    "The proposal makes it possible for doctors to directly prescribe cannabis as part of their treatment," the Swiss cabinet said in a statement.


    ZURICH: The Swiss government aims to make it easier for patients to get medical marijuana, proposing on Wednesday to allow prescriptions for cannabis to treat people suffering from cancer or other serious conditions.


    The proposal, separate from a Swiss government push to allow some cities to experiment with recreational marijuana, would replace the current system, in which those seeking medical cannabis must apply for an exception from the Federal Health Office to get what is otherwise an illegal drug.


    Marijuana is sometimes used to help cancer patients manage chronic pain, to help boost their appetites, and to reduce spasticity associated with multiple sclerosis.


    Read Also: North Dakotas first medical marijuana dispensary set to open


    "The proposal makes it possible for doctors to directly prescribe cannabis as part of their treatment," the Swiss cabinet said in a statement.


    "Growing and processing medical cannabis, as well as its sale, would then be possible under a system regulated" by Swissmedic, the country's drug regulatory agency.


    A formal comment period runs until mid-October.


    Just how insurers will handle reimbursement for medical marijuana will be dealt with separately, the government said.


    "The biggest obstacle to automatic reimbursement is that the scientific evidence of efficacy is not yet sufficient and the conclusions of existing studies are sometimes contradictory," the government said.


    The Federal Health Office will launch an evaluation project to help answer questions about whether the drug is an effective remedy and, if so, for what conditions, it said.


    Read Also: Thailand: Three Companies try to patent medical marijuana, applications suspended


    POT PUSH


    Switzerland cited increased use of medical marijuana in the treatment of a variety of conditions as driving its initiative. Federal authorities granted around 3,000 exceptions for people seeking to get medical marijuana in 2018.


    Elsewhere, medical marijuana is also booming.


    Portugal's parliament has approved a bill to legalise marijuana-based medicines, following in the footsteps of Italy, Germany, Canada and parts of the United States. Britain made a similar move in July 2018.


    Companies are moving, too.


    Swiss drugmaker Novartis last year struck a deal with Canadian medical cannabis maker Tilray to support commercialisation of some of its products.


    Separately, Switzerland is tinkering with laws that now forbid recreational marijuana, a potential precursor to joining other countries and an increasing number of U.S. states -- Illinois became the latest this week -- in legalising the drug.


    A plan released in February could let up to 5,000 people smoke marijuana in pilot studies.

    appetitescancercannabisdoctorsdrugHealthcaremarijuanamedicalMedical marijuanaNovartispharmapharma newsreimbursementSwiss GovtSwitzerlandtreatmentUnited States
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok